Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Mylan acquires rights to novel LAMA respiratory compound from Pfizer
The Fly on the Wall
Wednesday, December 18, 2013 - 9:52am
tags:
Mylan, LAMA, M&A, Pfizer
Amarin: Summarizing The Variables Involved In The Upcoming PDUFA
Seeking Alpha
Wednesday, December 18, 2013 - 9:44am
tags:
Amarin, FDA, Vascepa
Depomed nabs migraine treatment for $48.7M
Seeking Alpha
Wednesday, December 18, 2013 - 9:34am
tags:
Depomed, Cambia, M&A, Nautilus Neurosciences
Merck and GlaxoSmithKline partner to evaluate renal cell carcinoma regimen
The Fly on the Wall
Wednesday, December 18, 2013 - 9:16am
tags:
renal cell carcinoma, Merck, GSK, MK-3475, pazopanib
Novartis Answers Critics
TheStreet.com
Wednesday, December 18, 2013 - 9:14am
tags:
Novartis
Drugmakers urge FDA security audit after cyber breach
Yahoo/Reuters
Wednesday, December 18, 2013 - 9:11am
tags:
FDA, cybersecurity
Pfizer’s Deal on Generic Viagra Shows Treatment Changes
Bloomberg
Wednesday, December 18, 2013 - 8:29am
tags:
generics, Teva, Viagra, erectile dysfunction
Pfizer's 2013 Sets Up a Bright Future
Motley Fool
Wednesday, December 18, 2013 - 8:25am
tags:
Pfizer, Lyrica, patent cliff, Eliquis
3 Reasons Why Bristol-Myers Squibb Could Make an Awesome Comeback
Motley Fool
Wednesday, December 18, 2013 - 8:22am
tags:
Bristol-Myers Squibb
Drugmakers Favor Companies for Medical Education Grants
Bloomberg
Wednesday, December 18, 2013 - 8:21am
tags:
medical education, grants, CME
Recent Moves By Pfizer Management: No Big Deal Or Telegraphing A Sell-Off?
Seeking Alpha
Wednesday, December 18, 2013 - 8:20am
tags:
Pfizer
Will GSK's Sales And Marketing Changes Result In Lower Revenues?
Forbes
Wednesday, December 18, 2013 - 8:19am
tags:
GSK
The Race To Treat Stage III Melanoma Just Got A Lot More Interesting
Seeking Alpha
Wednesday, December 18, 2013 - 8:18am
tags:
melanoma, Amgen, Inovio, OncoSec Medical, TVEC
Novartis Needs Special Delivery for Potent Cell Therapy
Bloomberg
Wednesday, December 18, 2013 - 8:16am
tags:
Novartis, cancer cell therapy, CTL019
Pfizer, Teva reach deal to allow launch of generic Viagra by 2017
Yahoo/AP
Tuesday, December 17, 2013 - 3:02pm
tags:
Generic, Viagra, Pfizer, Teva, erectile dysfunction
FDA Puts Out Warning on J&J, Novartis ADHD Drugs
Wall St Cheat Sheet
Tuesday, December 17, 2013 - 3:01pm
tags:
JNJ, FDA, ADHD, Novartis, methylphenidate, Ritalin, Concerta
NeoStem: Final Data Is Just Around the Corner
Wall St Cheat Sheet
Tuesday, December 17, 2013 - 2:44pm
tags:
NeoStem, AMR-001
European Drug Agency Delays Trial-Data Policy Until March
Bloomberg
Tuesday, December 17, 2013 - 2:36pm
tags:
clinical trial data, EMA, Europe
Agenus: How Meaningful Is The Prophage Phase II Data?
Seeking Alpha
Tuesday, December 17, 2013 - 2:35pm
tags:
Agenus, Prophage, glioblastoma
Boehringer's blood clot drug shows promise in broader use trial
Yahoo/Reuters
Tuesday, December 17, 2013 - 10:58am
tags:
Boehringer Ingelheim, Pradaxa, blood thinners

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.